AlloSource Announces Two Presentations at the North American Spine Society Annual Meeting


Centennial, Colo. — September 25, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced two presentations on the use of biologics in spinal fusion surgery at AlloSource’s booth #2031 at the North American Spine…


AlloSource Named One of the 100 Healthiest Workplaces in America by Healthiest Employers


Centennial, Colo. — September 21, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced that Healthiest Employers® named AlloSource one of the 100 Healthiest Workplaces in America. Over 1,000 organizations across…


AlloSource Awards Dr. Kevin Shea the Annual Dr. Steven Gitelis Inspiration Award


Centennial, Colo. — July 17, 2018 — AlloSource, one of the largest nonprofit cellular and tissue networks in the country, offering life-saving and life-enhancing solutions in orthopedic, spine, burn and wound procedures to help restore patient health and mobility, today announced that it will award…


AlloSource Partners With Tuition.io to Help Employees Pay Down Student Debt


Centennial, Colo. — May 1, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced the rollout of its student loan repayment assistance program, a new employee benefit to help workers pay off their student loans…


AlloSource and Stryker Launch ProChondrix CR Cryopreserved Osteochondral Allograft


Centennial, Colo. – April 4, 2018 – AlloSource and Stryker today announced the launch of ProChondrix® CR, a cryopreserved osteochondral allograft. ProChondrix CR is a single-stage, natural solution for patients in need of articular cartilage repair. ProChondrix CR is designed to match biomechanical…


AlloSource Co-Authors International Space Station Microbial Study with NASA’s Jet Propulsion Laboratory


Centennial, Colo. — January 16, 2018 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts, and NASA’s Jet Propulsion Laboratory (JPL) co-authored a scientific publication titled “Detection of antimicrobial resistance genes associated with…


AlloSource Launches Placental Donation Program


Centennial, Colo. — December 20, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts that advance patient healing, today announced the launch of the AlloSource Placental Donation Program. This initiative provides the opportunity for…


AlloSource Announces Raime Leeby Muhle As Chief Financial Officer


Centennial, Colo. — December 14, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced the appointment of Raime Leeby Muhle as Chief Financial…


American Heart Association Recognizes AlloSource For Workplace Health Achievements


Centennial, Colo. — December 5, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced it received recognition from the American Heart…


AlloSource Announces Bob Lay As Chief Operating Officer


Centennial, Colo. — November 7, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced the appointment of Bob Lay as Chief Operating Officer.…


AlloSource President And CEO Thomas Cycyota Receives American Association Of Tissue Banks Award


Centennial, Colo. — October 10, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue and cellular allografts for use in surgical procedures and wound care to advance patient healing, today announced that its President and Chief Executive Officer, Thomas…


AlloSource And Integra LifeSciences Announce Anchor Gifts To Phoenix Society For Burn Survivors’ Never Alone Campaign


Centennial, Colo. and Plainsboro, N.J. — October 5, 2017 — AlloSource, one of the nation’s largest providers of cellular and tissue allografts, and Integra LifeSciences, a leading global medical technology company, today announced anchor gift donations to the Phoenix Society for Burn Survivors’…


Philadelphia Hand To Shoulder Center Of Thomas Jefferson University Announces Prospective Study On AlloWrap In The Hand And Wrist


Philadelphia, Pa. — August 8, 2017 — Researchers at the Philadelphia Hand to Shoulder Center (PHSC) of Thomas Jefferson University (TJU) today announced the initiation of a prospective, randomized trial for the treatment of tendon adhesions of the hand and wrist using AlloSource’s AlloWrap® DS, a…


AlloSource Releases AlloFuse Line Extentsion


Company adds AlloFuse Select CM, a cellular allograft matrix, to the AlloFuse portfolio Centennial, Colo. — August 1, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue, and cellular allografts to advance patient healing in surgical procedures and wound…


Theracell And AlloSource Announce Second Patent For Bone Fiber Technology


Demineralized Bone Fiber (DBF™) patent to expand TheraCell’s osteobiologic patent portfolio Northridge, Cali. and Centennial, Colo. — March 9, 2017 — TheraCell, a regenerative medicine company, today announced it was awarded a second patent for its demineralized bone fiber (DBF™) technology by the…


AlloSource Announces The Annual Dr. Steven Gitelis Inspiration Award


Company honors Dr. Brian Cole with the inaugural award Centennial, Colo. — January 24, 2017 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, announced the…


TheraCell And AlloSource Announce Issuance Of Patent For Bone Fiber Technology


Northridge, Calif. and Centennial, Colo. — Oct. 25, 2016 — TheraCell, a regenerative medicine company, today announced that the United States Patent and Trademark Office (USPTO) will issue TheraCell a patent for its demineralized bone fiber (DBF™) technology. The addition of this patent expands…


AlloSource Receives Phoenix Society For Burn Survivors’ Harman Award


Centennial, Colo. — October 21, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts to advance patient healing, received the Phoenix Society for Burn Survivors’ Harman Award for philanthropic leadership. The award is presented to an…


International Cartilage Repair Society Symposia To Highlight Early Findings Of ProChondrix Cartilage Restoration Matrix


Centennial, Colo. — September 23, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, will share early results of its fresh cartilage allograft, ProChondrix®…


AlloSource Supports NASA And Jet Propulsion Laboratory On Microbial Study


Centennial, CO — August 25, 2016 — AlloSource, one of the nation’s largest providers of skin, bone and soft tissue allografts for use in surgical procedures and the world’s largest processor of cellular bone allografts, worked with NASA and the Jet Propulsion Laboratory (JPL) on microbial research…


AlloSource Receives Orthopedics This Week Sports Medicine Award For ProChondrix Cartilage Restoration Matrix


Centennial, Colo. — July 7, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, today announced that it received Orthopedics This Week’s first annual Sports…


Preclinical Study Validates Science Behind AlloSource’s AlloStem Cellular Bone AlloGraft


Centennial, Colo. — July 6, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, today announced that Dr. Nicole Ehrhart, Professor of Surgical Oncology at the…


AlloSource Announces Two Innovative Bone Fiber AlloGrafts


AlloFuse® Cortical Fibers and AlloFuse® Fiber Boat will expand the company’s osteobiologic bone graft portfolio Centennial, Colo. — June 13, 2016 — AlloSource, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and…


AlloSource Distributes First Bioengineered Blood Vessels For Humacyte Phase III Clinical Trial


Centennial, Colo. — May 23, 2016 — AlloSource®, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, today announced the distribution of investigational bioengineered blood…